Dr. Nemazee initially gravitated to exploring the mechanisms of autoimmunity while a graduate student at Harvard University, Boston. His mentor was interested in studying the network hypothesis and Dr. Nemazee was assigned to making monoclonal antibodies. The current focus of his laboratory is on the innate immune response. The Crafoord Prize, coming at this stage of his career, he says, “is definitely the most significant that I have ever received. I’m very honored and grateful.”
Dr. Goodnow originally began his scientific career studying veterinary medicine and surgery, then shifted to immunochemistry and immunology, obtaining his doctorate at the University of Sydney. He also trained in DNA technology at Stanford University, Palo Alto, Calif. Currently, he is leading Hope Research, an initiative of the Garvan Institute. For Dr. Goodnow, being notified of the Crafoord Prize “was the most amazing phone call of my life! And I’m really thrilled that the topic is getting its day in the sun.”
Gretchen Henkel is a health and medical journalist based in California.
